Press

September 18, 2024 – The Society for Clinical Research Sites (SCRS) is proud to announce a new partnership with AMR (Alliance for Multispecialty Research) as part of the SCRS Global Impact Partner (GIP) program. Founded in 1994 as an independent clinical research site network, AMR consolidated in 2017 and now operates as a fully integrated site organization. AMR is an award-winning leader in the clinical research field due to its dedication to excellence, custom-tailored project delivery and operational efficiencies. “Joining the Global Impact Partner program solidifies AMR’s continued commitment to support the pillars of SCRS,” said William Smith, CEO of AMR. “Our team is eager to collaborate with other GIPs to support the vision of SCRS and ensure site sustainability through advocacy, education, connection and mentorship.” “AMR has been a research site member of SCRS since our inception, with CEO Dr. William Smith as a valued contributor to the SCRS Leadership Council and Workforce Task Force,” said Allyson Small, Chief Operating Officer of SCRS. “SCRS is thrilled to deepen our collaboration with AMR, whose expertise and leadership have continually driven forward our shared mission. We are excited to further leverage their insights and resources as a Global Impact Partner, empowering us to better serve the research site community together.” The SCRS Global Impact Partner program is designed to foster collaboration between clinical research organizations and sites, ensuring that the voices of all partners are heard and that best practices are shared across the industry. For more information about SCRS Global Impact Partnership, please visit myscrs-new.local/industry-partnerships/global-impact-partners. About AMR (Alliance for Multispecialty Research)AMR (Alliance for Multispecialty Research) is a premier integrated site company dedicated to conducting high-quality, ethical research with a focus on patient welfare. With over 30 research centers across the United States, AMR is committed to driving the development of medical treatments and fostering professional growth within the industry. Learn more at amrllc.com. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

September 17, 2024 – The Society for Clinical Research Sites (SCRS) is excited to announce Mural Health’s designation as a Global Impact Partner. Mural Health was founded in 2022 by Sam Whitaker (previously founder and CEO of Greenphire) to create a platform that is focused on making clinical trial participation easier for participants and caregivers. Mural’s Health’s participant management platform, Mural Link, offers advanced participant payments, travel and concierge services, site and participant communication, and reporting. In addition to Mural Link, Mural Health leads a variety of initiatives designed to enhance the clinical trial experience for patients and caregivers through empathy-centered innovation. Mural Health led the creation, and subsequent congressional sponsorship, of The Harley Jacobsen Act. The Act was introduced to Congress in February 2024 and seeks to exclude all payments to all participants (patients and caregivers) in all approved clinical trials from being treated as taxable income. In 2023, in line with its ethos, Mural Health funded and introduced The Portrait Project, offering the world a glimpse into the personal journeys of clinical trial participants. Joining SCRS is another step in Mural Health’s mission to relieve the trial-related burdens of participants and allow sites to focus on who matters most: patients and caregivers. “At Mural Health, we are committed to breaking down barriers that hinder clinical trial participation, including payment complexities and discriminatory tax laws”, said Sam Whitaker, co-founder and CEO of Mural Health. “We are thrilled to join SCRS as a Global Impact Partner to drive critical conversations around these issues, enable sites and sponsors to improve the experience for their participants, and ultimately make clinical trials accessible and equitable for all.” “Mural Health’s collaboration with SCRS as a Global Impact Partner highlights our shared commitment to advancing clinical trial accessibility and reducing administrative burden for research sites,” said Marcus Maleck, Vice President of Global Business Partnerships with SCRS. “Their team’s dedication to simplifying trial participation is making great strides to improve the efficiency and accessibility of clinical trials around the world. Mural Health’s focus on overcoming financial and logistical obstacles will significantly benefit our site community and the broader research landscape.” About Mural Health Mural Health stands at the forefront as a patient-first technology innovator, devoted to simplifying clinical research for participants. The company targets areas ripe for significant enhancement, providing technological solutions designed to ease participation burdens for patients and caregivers alike, both locally and globally. The Company’s platform, Mural Link, integrates features that streamlines participant payments, travel coordination, communication, and satisfaction measurement, Mural Health is dedicated to improving the clinical trial experience as it continues to expand its platform to offer additional feature sets. The Company anticipates the release of several disruptive products, aimed at overhauling inefficiencies that are nurtured and perpetuated by established companies that prioritize profits over sick patients. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

September 5, 2024 – The Society for Clinical Research Sites (SCRS) is pleased to announce the addition of EMS Healthcare to its esteemed Global Impact Partner program. EMS Healthcare, a leader in providing flexible medical and community-based clinical research facilities, joins this distinguished group of partners dedicated to advancing site sustainability and research innovation.   EMS Healthcare is recognized for its commitment to developing and delivering accessible medical solutions directly within the heart of communities, by advancing clinical research through people-centric solutions that enhance health outcomes and reduce health inequalities. The partnership underscores its dedication to ensuring that clinical research is inclusive, diverse, and equitable.  Dr. Clare Grace, CEO of EMS Healthcare, expressed her enthusiasm about the partnership, stating: “The SCRS community is instrumental in shaping and sharing best practices across clinical research sites. Our solutions are designed to make health services more accessible, and this partnership will enable us to further support clinical research programs in reaching, recruiting, and retaining diverse participants at speed and scale.”  Marcus Maleck, SCRS Vice President of Global Business Partnerships, shared, “SCRS enthusiastically welcomes the EMS Healthcare team to the Global Impact Partner program. This collaboration will allow EMS Healthcare to meaningfully contribute to SCRS’s mission, leveraging its expertise to foster greater inclusivity and accessibility in clinical trials. Together, we will continue to advocate for sites and enable solutions to support patient diversity and inclusivity in research.”  Global Impact Partners have the opportunity to engage in various SCRS initiatives, including participation in industry events and contributing to thought leadership that addresses key challenges in clinical research. Learn more about the GIP program at myscrs-new.local/industry-partnerships/global-impact-partners.  About EMS Healthcare  EMS Healthcare enables the development and delivery of medical solutions deep within the heart of communities. We are committed to supporting clinical trials and population health services within underserved communities and addressing health inequalities. EMS Healthcare’s dedication to a more inclusive and equitable healthcare landscape aligns with its vision to create a future where good health is within everyone’s reach.  About the Society for Clinical Research Sites (SCRS)  The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success. 

August 20, 2024 – Elixia, a leader in complex clinical research, has joined the Society for Clinical Research Sites (SCRS) as a new Global Impact Partner (GIP). Elixia combines the robust capabilities of premier clinical research sites with a leading patient recruitment engine offering comprehensive solutions to sponsors and CROs. Elixia’s clinical research sites focus on cardiology/nephrology, psychiatry/neurology, complex metabolic and infectious disease across diverse patient populations spanning outpatient and inpatient settings. Elixia’s patient recruitment solutions, CSSi, uses both traditional and digital media to help find patients to participate in trials, while also offering site support through local enrollment specialists. This multifaceted approach offers sponsors and sites a variety of tactics that influence patient identification, recruitment and retention across geographies and demographics. “The SCRS community contributes so much to advancements in clinical research,” said Dustin Owen, Elixia CEO. “We are privileged to become a Global Impact Partner, joining the community of leading site networks, sponsors, CROs, and solution providers. We look forward to working collaboratively to foster advancements that will benefit patients, sites, and sponsors.” “SCRS is proud to welcome Elixia to the Global Impact Partner program,” shared Marcus Maleck, Vice President of Global Business Partnerships with SCRS. “Elixia’s expertise on trial agility will be invaluable as we work together to enhance the clinical trial process and support site sustainability. Their contributions will be instrumental in advancing the efficiency of clinical trials, benefiting sites and patients alike.” The Global Impact Partnership offers industry sponsors, CROs, service providers and research sites an opportunity to align with SCRS’ mission of ensuring site sustainability. Elixia will provide input on strategic initiatives for the organization and contribute to SCRS events, committees, publications, advocacy and education for research sites. For more information on about the GIP Program, visit myscrs-new.local/industry-partnerships/global-impact-partners/. About Elixia Elixia is an industry-leading clinical research entity, linking a network of multi-site clinical research facilities with a global patient recruitment operation. With sites in California, Florida, Massachusetts, Missouri, Michigan, and Texas, Elixia conducts Phase I-IV studies, addressing complex conditions in metabolic health, nephrology, neuroscience, and infectious diseases. Elixia is renowned globally for its technological prowess, which enhances efficiency in patient acquisition and offers critical health outcome data that provides invaluable insights to sponsors worldwide. For more information, please visit elixiahealth.com. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

August 13, 2024  –  The Society for Clinical Research Sites (SCRS) proudly welcomes Suvoda, a global clinical trial technology company specializing in complex studies, to its Global Impact Partner (GIP) program. Operating in more than 85 countries with research sites in thousands of locations, Suvoda has conducted over 1,500 clinical trials focusing mainly on oncology, rare diseases, and CNS. The company’s single platform delivers eConsent, Interactive Response Technology (IRT), and electronic Clinical Outcome Assessment (eCOA). The SCRS GIP program fosters a synergistic partnership between industry leaders and research sites to develop site-focused initiatives and solutions. By joining the GIP program, Suvoda will collaborate with research sites and industry partners, offering global expertise in alignment with the program’s mission. “As clinical trials increase in complexity and new technologies emerge, we are excited to work with SCRS and its member sites to transform the patient journey in a clinical trial,” said Rob Hummel, President and Chief Operating Officer at Suvoda. “Our focus is on making our products more intuitive, robust and streamlined so that site teams have the tools they need to calmly guide their patients through some of the most challenging moments of their lives.” “Suvoda is a valuable addition to our passionate GIP community, bringing specialized experience and a strong commitment to clinical research efficiency,” commented Marcus Maleck, Vice President of Global Business Partnerships with SCRS. “Suvoda’s focus on optimizing clinical trial technology and processes, especially in complex therapeutic areas, is commendable. Working closely with SCRS’ global network of research sites and industry leaders, Suvoda will help advance site-centric solutions that address unique challenges in life-changing trials.” The SCRS GIP program offers industry sponsors, CROs, service providers and research sites an opportunity to align with SCRS’ mission of ensuring site sustainability. Learn more about the GIP program at myscrs-new.local/industry-partnerships/global-impact-partners.     About Suvoda Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,500 trials across 85 countries. To learn more, visit suvoda.com. Follow Suvoda on LinkedIn.   About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.  

July 30, 2024 – The Society for Clinical Research Sites (SCRS) is thrilled to announce a Global Impact Partnership with Pacific Clinical Research Network (PCRN), the largest clinical trial network in New Zealand. The SCRS Global Impact Partner (GIP) program is comprised of clinical research sites, sponsors, CROs, and professional service providers, which enables a unique opportunity to engage with SCRS and its site members. Pacific Clinical Research Network was established in 2021 through a merger of Lakeland Clinical Trials Group and Southern Clinical Trials Group which have been in operation since 2002. In 2023, PCRN expanded its offering and has a brand-new purpose-built Early Phase Unit in Auckland which now complements their late phase sites. As one of the country’s leading private clinical research companies, PCRN offers a streamlined, integrated nationwide partner network of nine private clinical research trial sites across New Zealand. “Having been a longstanding member and supporter of SCRS, we are excited to join as a GIP member, a move that perfectly aligns with PCRN’s core vision of bridging healthcare and research through collaboration. As a leading clinical trial provider, this partnership strengthens our ability to collaborate with other sites, sponsors, and CROs, driving healthcare excellence and keeping participants and quality at the forefront of clinical research,” said Rosie McKellar, CEO of PCRN. “This strategic collaboration with PCRN marks a significant milestone for both organizations. As SCRS’ first GIP in New Zealand, working with PCRN will set a new standard for collaboration and innovation worldwide,” added Marcus Maleck, Vice President of Global Business Partnerships with SCRS. “SCRS welcomes the PCRN team to this esteemed coalition aimed at ensuring research site success and sustainability. With PCRN’s resources and expertise, SCRS and its partners are poised to drive forward advancements that will benefit the entire clinical research ecosystem.” For more information about the SCRS Global Impact Partner Program,  visit myscrs-new.local/industry-partnerships/global-impact-partners. About Pacific Clinical Research Network PCRN is a leading research network of clinical trial sites, closely connected to General Practice clinics. Over the past 22 years, they have significantly contributed to the evolution of clinical trial facilities in New Zealand, becoming the largest clinical trial site network in the country. With a participant-first focus, PCRN conducts clinical trials across all phases and a diverse range of therapeutic areas. https://pcrn.co.nz/ About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

July 23, 2024   ̶   Alcanza Clinical Research, a mission-focused investigator site network, is excited to announce its affiliation with The Society of Clinical Research Sites (SCRS) as a Global Impact Partner. The GIP program is a community of industry sponsors, CROs, service providers and research sites elevating the site voice within clinical research. Since its inception in 2021, Alcanza has been an active supporter of SCRS initiatives. As a past president and current board member of SCRS, Alcanza’s Chief Commercial Officer, Casey Orvin, remains highly engaged and committed to expanding awareness and industry involvement with  SCRS. As a Global Impact Partner, Alcanza will help drive SCRS’ mission of ensuring site sustainability through advocacy, thought leadership, event participation and education.  “Strengthening our commitment to SCRS is a core part of our growth strategy,” said Carlos Orantes, Alcanza CEO. “SCRS understands the power of collaboration, especially when it involves advancing life-changing and life-saving new medicines. The GIP program is an excellent example of effective collaboration across large site networks, emerging sites, sponsors, CROs and solution providers – the stakeholders who make positive change and progress possible.” Sean Soth, Senior Vice President of Global Business Partnerships and Strategy with SCRS added: “Alcanza is a forward-looking organization that epitomizes the expanding role of the research site. By extending traditional research boundaries through their emphasis on diverse participation and community partners, Alcanza is setting a new standard for inclusive research that will benefit all site members and the broader clinical research community. SCRS looks forward to collaborating with Alcanza to advance our collective mission to enhance site sustainability.”’ For more information about the SCRS Global Impact Partner program, visit https://myscrs.org/. About Alcanza Clinical Research Alcanza is an integrated network of research facilities dedicated to reducing barriers to clinical research participation, especially in underrepresented patient populations. The network includes over 30 sites strategically located across the Southeast, Northeast, and Midwest regions of the United States, including Puerto Rico. Alcanza supports studies that span all trial phases and major therapeutic areas. www.AlcanzaClinical.com About The Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.  

July 11, 2024 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to clinical research site sustainability, is pleased to announce the launch of the 2024 SCRS Ambassador Program with three virtual symposiums in October and November. The SCRS Ambassador Program cultivates a network of influential research industry professionals who aim to bridge the gap between clinical research sites within their respective regions. Through virtual symposiums, research sites will gain essential business strategies and insights on regional research trends and technology with opportunities to collaborate with industry partners. Regional sites attending the symposiums will also receive a one-year scholarship for SCRS membership. Current SCRS Ambassador Program events include virtual symposiums for research professionals in Asia, Africa, and Latin America. Registration for the three symposiums is now available at myscrs-new.local/industry-partnerships/ambassador-program. “As a global organization, SCRS recognizes the importance of building and supporting a strong community of clinical research collaborators. The Ambassador Program represents a significant step towards creating a more united clinical research landscape,” commented Michael Pierre, SCRS Project Manager and Ambassador Program Lead. “Our goal is to foster advocates for clinical research sites internationally, empowering researchers to enhance their operations, partnerships, and trial outcomes. By providing a platform to promote collaboration and knowledge-sharing, the program will equip sites with the insights and tools needed for long-term success.” Early support for the Ambassador Program comes from Cognizant, Greenphire, Lilly, PPD, part of Thermo Fisher Scientific, Sanofi, and Scout Clinical. Regional Ambassador Program country leads and corporate sponsors have the opportunity to identify new research collaborations with participating sites and industry counterparts. For more information about the SCRS Ambassador Program, visit myscrs-new.local/industry-partnerships/ambassador-program.   About The Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

June 6, 2024 – The Society for Clinical Research Sites (SCRS) proudly announces the addition of EmVenio Research to its Global Impact Partner (GIP) Program. EmVenio, a PCM Trials company, is part of the largest independent decentralized clinical trial (DCT) site network and a premier provider of local clinical trial access globally. With sites located in the United States and the United Kingdom, EmVenio Research is committed to improving access to clinical trials within underrepresented communities and diverse patient populations. EmVenio leverages the combination of mobile sites to enter new communities and research sites in existing community hospitals, to expand the reach of the traditional site network ecosystem. With sites more conveniently located to patients, travel, schedule, and daily life challenges are minimized resulting in improved willingness to participate and remain on studies. Thad Wolfram, President of EmVenio Research, states, “Becoming a Global Impact Partner with SCRS marks another significant step for EmVenio in raising awareness about the evolution of clinical research sites. We are thrilled to join such a positive and collaborative organization, where mutual growth and learning are encouraged.” Marcus Maleck, VP of Global Business Partnerships added, “Collaborating with EmVenio through this partnership opens up opportunities for sites, patients and industry to build stronger connections. We admire EmVenio’s commitment to innovation and dedication to increasing accessibility to clinical research around the world, truly making a global impact. SCRS is excited to partner with the EmVenio team and explore how we can collectively work to bring our clinical ecosystem together.” The SCRS GIP program brings together industry leaders to drive innovation and improve site sustainability, patient engagement, and clinical trial performance. Through this partnership, EmVenio will contribute to the program’s goals of advancing clinical research practices and fostering a more collaborative research environment. To learn more about the Global Impact Partner program, visit scrsprograms.com. About EmVenio Research EmVenio Research, a PCM Trials Company, provides a scalable network of clinical trial sites strategically located in underrepresented communities to engage a diverse patient demographic. Our extensive global network comprises highly skilled clinicians, leading principal investigators, and cutting-edge research sites, allowing us to deliver high-quality clinical research services that prioritize reducing the burden on patient participation. Visit emvenio.com to learn more. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

May 21, 2024 – Elite Research Network, a consortium of multi-specialty sites, proudly announces its partnership with the Society for Clinical Research Sites (SCRS) as a Global Impact Partner (GIP). Founded in 2004, Elite Research Network is comprised of over fifty geographically diverse sites across the United States, conducting studies in most therapeutic areas and phases while earning a reputation for high enrollment and quality data. Chris Hoyle, Founder and CEO, has been a valued contributor to SCRS for many years as part of its Leadership Council and Global Summit committee, bolstering the development of educational content and resources for the site community. The GIP program is comprised of research site networks, industry sponsors, CROs, and service providers committed to ensuring site sustainability. As a GIP, Elite Research Network will expand its working relationship with SCRS to further amplify the site voice within the clinical research community. “Elite Research Network has enjoyed our partnership with SCRS since their inception,” said Chris Hoyle, CEO, Elite Research Network. “Much of our growth and success can be attributed to our involvement in SCRS and the networking opportunities our affiliation has provided throughout the years. We look forward to celebrating Elite Research Network’s 20th anniversary at the SCRS Global Site Solutions Summit this September in Hollywood, Florida.” “Since SCRS’ inception, Elite Research Network has been an instrumental partner in our collective work to improve site sustainability,” said Sean Soth, SVP of Strategy and Global Business Partnerships with SCRS. “We are thrilled to further our impact with Elite Research Network in this expanded partnership. As one of the first sites within the GIP program, they will have additional pathways for communication and collaboration between sites and industry partners. We look forward to facilitating greater synergy between industry stakeholders to advance clinical research practices and ensure site success.” To learn more about the GIP community, visit scrsprograms.com. About Elite Research Network Elite Research Network is a group of top-performing investigative sites throughout the United States specializing in a variety of therapeutic areas across all phases of clinical research.  We are dedicated to decreasing study start-up timelines and helping our clients meet their enrollment goals on time and on budget. About The Society for Clinical Research Sites (SCRS)The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000+ research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

April 22, 2024 – Clinical Research Billing, a leading provider of revenue management services for independent clinical research sites, is proud to announce its partnership with the Society for Clinical Research Sites (SCRS) as a Global Impact Partner. This collaboration underscores Clinical Research Billing’s commitment to enabling the financial success of clinical research sites. Clinical Research Billing specializes in tailored solutions for clinical research sites, including Clinical Trial Management System (CTMS) management, financial reporting, and billing services for industry-sponsored clinical trials. With a focus on maximizing site revenue and streamlining financial processes, Clinical Research Billing ensures that sites receive proper compensation for all billable items per contractual payment terms. “We manage the sites’ CTMS, invoice for all work completed, reconcile, follow up on unpaid invoices and visits, and advocate for sites’ financial interests. We provide monthly financial reports so the site owners can quickly grasp their financial situation,” said MaryAnn Bowman, a Company Founder. Kristi Etchberger, also a Founder, added, “Our objective is to keep research sites strong, healthy, and growing. By outsourcing services to our team, sites benefit from our experience, processes, and reporting in clinical research billing. The sites’ success is our success.” “Ensuring clinical research sites have the necessary education and resources to thrive financially is fundamental to SCRS’s mission,” commented Marcus Maleck, Vice President of Global Business Partnerships with SCRS. “Our partnership with Clinical Research Billing exemplifies this shared commitment, and SCRS warmly welcomes their team to our Global Impact Partner program. We look forward to collaborating closely to support the financial literacy and sustainability of the clinical research community.” As a Global Impact Partner, Clinical Research Billing will collaborate closely with SCRS to enhance resources, education, and advocacy efforts for the research site community. Together, they will work towards advancing best practices in financial management and empowering site sustainability. About Clinical Research Billing Clinical Research Billing was established in 2015 by Kristi Etchberger and MaryAnn Bowman after they had implemented a CTMS in a research site. They realized how challenging it was to implement but also how important a CTMS is for the site’s financial management. After that experience, they thought other sites might need the same support and launched Clinical Research Billing.  The company has grown and now has team members who work in multiple Clinical Trial Management Systems for sites throughout the United States. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.Share

April 17, 2024 – AiCure, a leading provider of patient-centric eClinical trial management solutions, has proudly joined the Society for Clinical Research Sites (SCRS) Global Impact Partner (GIP) program. The GIP program offers industry sponsors, CROs, service providers and site networks an opportunity to align with SCRS’ mission of ensuring site sustainability while contributing to SCRS events, advocacy and education for research sites. This strategic collaboration will enable AiCure to work directly with clinical research sites and industry partners to develop site-focused solutions to improve efficiency within clinical trials. “AiCure’s partnership with the Society for Clinical Research Sites (SCRS) is a significant step in supporting the global clinical research site community,” commented Ed Ikeguchi, CEO of AiCure. “As an AI and data analytics company focused on improving clinical trials, AiCure’s collaboration with SCRS will allow us to better understand the needs and challenges faced by clinical research sites. Our ability to collaborate with sites has been a key part of a shared vision to deliver better patient engagement and the highest quality data for sponsors. This partnership with SCRS will further enable AiCure to develop more effective solutions that reduce the burden on sites and optimize their operations, ultimately enhancing the overall conduct of clinical trials.” “As we welcome AiCure to the Global Impact Partner program, we recognize their invaluable expertise and solutions that contribute to clinical research site sustainability and trial outcomes,” said Marcus Maleck, Vice President of Global Business Partnerships with SCRS. “AiCure’s dedication to alleviating the technological burden on clinical site personnel through innovative solutions directly aligns with SCRS’ mission. By providing sites with capabilities to address trial challenges and foster participant engagement, AiCure has demonstrated its commitment to reduce site workload and streamline research processes.” For more information about the SCRS Global Impact Partner program, visit scrsprograms.com. About AiCure AiCure, founded in 2012, developed the world’s first patient engagement AI, a comprehensive platform that extends the reach of your care team into the patient’s home and life—more seamlessly, frequently and effectively. The platform combines AI, computer vision, synchronous & asynchronous communication, predictive analytics and extensive site support to drive sponsors, sites and participants’ understanding forward—from adherence through digital biomarkers and beyond. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.Share

April 4, 2024 – The Society for Clinical Research Sites (SCRS) is pleased to welcome Translational Drug Development (TD2) as an SCRS Global Impact Partner and Oncology Spirit Partner. TD2 is a leading provider of comprehensive preclinical drug development, translational and clinical trial services based in Scottsdale, Arizona. SCRS Global Impact Partners (GIP) are comprised of industry sponsors, CROs, service providers, and site networks that are dedicated to supporting SCRS’ mission of ensuring site sustainability. GIP representatives participate in the development of SCRS events, advocacy initiatives, and educational content for research sites. With TD2’s involvement as an Oncology Spirit Partner, the organization will contribute to the SCRS Oncology Program, creating site-focused resources for oncology research success. TD2 will also exhibit at the SCRS Oncology Site Solutions Summit on April 10-11, 2024, in Atlanta, Georgia. The Oncology Site Solutions Summit brings together research sites, sponsors, CROs, and solution providers to learn and share solutions for more efficient oncology research operations. “We are thrilled to partner with SCRS in their important mission advocating for sites,” said Susan Night, Vice President of Site Engagement and Network Strategy for TD2. “It aligns perfectly with TD2’s commitment to building purposeful partnerships aimed at advancing science through clinical research with the goal of improving access to novel therapeutics and outcomes for patients.” “Collaboration is a key ingredient to the future of precision medicine,” shared Sean Soth, SVP of Strategy and Global Business Partnerships for SCRS. “TD2 brings a unique approach and suite of services into our GIP community as a CRO focused on precision oncology. In many ways, our network can learn alongside TD2 about opportunities for sites and industry to collaborate,”  continued Soth. “SCRS Global Impact Partners are committed to addressing challenges faced by research sites today. As a leading precision oncology CRO, TD2 brings unparalleled expertise and resources to advance clinical research and drug development in the oncology space. By aligning our efforts, we can make substantial strides in ensuring sustainable cancer research and improving patient outcomes.” For more information about the SCRS GIP program, visit scrsprograms.com. About Translational Drug Development (TD2) TD2 is a leader in precision oncology, providing innovative services for improved drug development. Using a dedicated, expert team with broad experience and understanding in cancer medicine, TD2 is uniquely positioned to support accelerated development of novel therapeutics. Rigorous and high-throughput translational preclinical development services, combined with regulatory affairs expertise, enables customized clinical trial design and execution. Our unique Oncology Ecosystem encourages the timely selection of patient populations who are most likely to benefit from a new agent, and the rapid identification of clinically significant endpoints. TD2 is committed to reducing the risks and uncertainty inherent in the drug development process with the ultimate goal of accelerating patient access to promising treatments. For more information, visit www.TD2inc.com. About the Society for Clinical Research Sites (SCRS) The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

March 27, 2024 – The Society for Clinical Research Sites (SCRS) is pleased to welcome Accelerate Recruitment Services, a leading provider of patient recruitment solutions for clinical trials, as a Global Impact Partner (GIP). The SCRS GIP program offers industry sponsors, CROs, service providers and site networks an opportunity to align with SCRS’ mission of ensuring site sustainability while contributing to SCRS events, advocacy and education for research sites. This collaboration signifies a significant milestone in the ongoing efforts to revolutionize patient recruitment within the research industry and enhance site operations. Accelerate Recruitment Services specializes in assisting patients, research sites and sponsors in achieving their clinical trial enrollment objectives through a comprehensive range of services. Their offerings encompass strategic recruitment planning, meticulous execution of patient recruitment initiatives, and effective strategies for patient retention. Carlos Bussey, Co-Founder and CEO of Accelerate Recruitment Services shared, “We are proud to announce our partnership with SCRS, a pivotal collaboration aimed at advancing critical initiatives in clinical research. With our roots originating at the site level, we deeply understand the recruitment and retention challenges sites face, and we are committed to amplifying their voices and perspectives. By joining forces as a Global Impact Partner, Accelerate Recruitment Services aspires to elevate patient participation in clinical trials by fostering a seamless flow of engagement through innovative recruitment solutions and technology. Our shared vision is to empower sites to maximize their efforts, surpass enrollment goals, and ultimately drive transformative outcomes in the realm of clinical research.” “SCRS is thrilled to announce Accelerate Recruitment Services as our newest Global Impact Partner,” commented Marcus Maleck, Vice President of Global Business Partnerships with SCRS. “Our extensive GIP community values collaboration, transparency, and site-centricity to drive their work forward. This partnership signals a shared dedication to pioneering innovation and enhancing site sustainability, directly impacting sites and patients worldwide.” For more information about the SCRS Global Impact Partner program, visit scrsprograms.com/global-impact-partnership. About Accelerate Recruitment Services Accelerate Recruitment Services is committed to assisting sponsors and research sites to efficiently achieve clinical trial enrollment objectives. Our mission is to enhance patient recruiting efficiency while promoting diversity and bolstering retention through tailor-made technology and marketing solutions. To achieve this, we have developed TruView, an integrated marketing platform and communication tool designed to expedite patient enrollment in clinical trials through targeted marketing and seamless communication. TruView has revolutionized the recruitment process by ensuring swift, transparent, and effective engagement. It monitors recruitment activity in real-time, streamlines communication between sites and patients, and provides comprehensive reports with key performance indicators for informed decision-making to recruit faster, attract diversity, and retain more patients in clinical trials. About The Society for Clinical Research Sites (SCRS)The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000+ research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.

January 11, 2024 – The Society for Clinical Research Sites (SCRS) is proud to introduce the evolution of its growing Diversity Site Solutions Summit and Diversity Awareness Program. In response to the increasing imperative for inclusive clinical trials, the Diversity Summit will now be rebranded as the “IncluDE Site Solutions Summit” and the Diversity Awareness Program will be known as the “IncluDE Program”. The updated names signify a pivotal moment for SCRS and industry partners working to enable more diverse, equitable and inclusive clinical trials. Both programs will continue to champion diverse clinical trial participation by sharing proprietary research, resources and guidance to ensure clinical research reflects the rich tapestry of the global population. “SCRS feels that ‘IncluDE’ better reflects the objectives of these critical programs, which is assuring clinical research is inclusive and equitable for all communities that want to participate,” said Jackie Kent, Vice President of Diversity & Special Projects at SCRS. “Diversity often focuses on race and ethnicity, while inclusivity spans gender identity, sexual orientation, religion, persons with disabilities, socioeconomic status and more. As the industry works towards more accessible clinical trials, we must prioritize making all communities feel that they are truly welcome and able to participate in life-changing research.” With a heightened focus on inclusive practices, the programs will continue to serve as a premier platform for industry stakeholders to collaboratively advance initiatives that empower underrepresented populations to access clinical trials and healthcare. The third annual IncluDE Site Solutions Summit will be held at the Loews Hotel in Atlanta, Georgia from April 8-9, 2024. About the Society for Clinical Research Sites The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 10,000 sites in 47 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs-new.local/. Our voice. Our community. Your success.